Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, to Compare Non-inferiority Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis.
Conditions
Interventions
Acyclovir 50mg/g
Penciclovir 10mg/g
Locations
1
Brazil
Flavia Addor
São Paulo, São Paulo, Brazil
Start Date
February 1, 2012
Primary Completion Date
March 1, 2012
Completion Date
October 1, 2012
Last Updated
March 4, 2013
NCT02965781
NCT03977792
NCT00306293
NCT03310294
NCT03307772
NCT02207881
Lead Sponsor
EMS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions